Treatment outcomes of macrolide-resistant mycobacterium avium complex lung disease

Seong Mi Moon (Seoul, Republic of Korea), Seong Mi Moon, Hye Yun Park, Su-Young Kim, Kyeongman Jeon, Seung-Heon Lee, Chang Ki Kim, Sung Jae Shin, Won-Jung Koh

Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Seong Mi Moon (Seoul, Republic of Korea), Seong Mi Moon, Hye Yun Park, Su-Young Kim, Kyeongman Jeon, Seung-Heon Lee, Chang Ki Kim, Sung Jae Shin, Won-Jung Koh. Treatment outcomes of macrolide-resistant mycobacterium avium complex lung disease. Eur Respir J 2016; 48: Suppl. 60, 2567

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Retrospective observation of mycobacterium avium complex lung disease followed without treatment
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013

Efficacy and safety of kanamycin addition in patients with drug-refractory mycobacterium avium complex lung disease
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation
Year: 2015


Development of a prognostic scoring system for Mycobacterium avium complex lung disease
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016


Isolation of M. abscessus from patients with M. avium complex (MAC) lung disease
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013

Treatment of refractory mycobacterium avium complex lung disease with a moxifloxacin-containing regimen
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013

LATE-BREAKING ABSTRACT: Genotyping mycobacterium avium has a clinical potential to predict therapeutic responses of the lung infection
Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system
Year: 2013


Retrospective investigation of patients positive for glycopeptidolipid-core antibody to mycobacterium avium complex pulmonary disease
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014


Characteristics of patients with isolation of mycobacterium xenopi
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013

Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype
Source: Eur Respir J, 50 (3) 1602503; 10.1183/13993003.02503-2016
Year: 2017



Clinical characteristics and treatment outcomes of patients with macrolide-resistant Mycobacterium avium complex pulmonary disease: a systemic review and meta-analysis
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019


Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019


Factors related to response to intermittent treatment of mycobacterium avium complex lung disease
Source: Eur Respir J 2006; 28: Suppl. 50, 557s
Year: 2006

Susceptibility to nontuberculous mycobacterial lung disease
Source: Eur Respir J 2008; 31: 1322-1333
Year: 2008



Clinical analysis of pulmonary Mycobacterium avium complex disease in Japan
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012

Paradoxical response during antibiotic treatment in patients with Mycobacterium avium complex lung disease
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020


Clinical relevance of Mycobacterium simiae in pulmonary samples
Source: Eur Respir J 2008; 31: 106-109
Year: 2008



Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments
Source: Eur Respir Rev, 31 (163) 210212; 10.1183/16000617.0212-2021
Year: 2022



Risk factors for Mycobacterium tuberculosis infection among contacts of pulmonary tuberculosis patients
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012


Association between injectable aminoglycoside treatment duration and outcomes in cavitary Mycobacterium avium complex lung disease
Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria
Year: 2018



Nontuberculous mycobacterial lung disease caused by Mycobacterium parascrofulaceum in an immunocompetent patient
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014